133 related articles for article (PubMed ID: 37666247)
21. Fluorescence spectroscopy for the detection of potentially malignant disorders and squamous cell carcinoma of the oral cavity.
Francisco AL; Correr WR; Azevedo LH; Kern VG; Pinto CA; Kowalski LP; Kurachi C
Photodiagnosis Photodyn Ther; 2014 Jun; 11(2):82-90. PubMed ID: 24704941
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of an autofluorescence based imaging system (VELscope™) in the detection of oral potentially malignant disorders and benign keratoses.
Awan KH; Morgan PR; Warnakulasuriya S
Oral Oncol; 2011 Apr; 47(4):274-7. PubMed ID: 21396880
[TBL] [Abstract][Full Text] [Related]
23. Comparative evaluation of autofluorescence imaging and histopathological investigation for oral potentially malignant disorders in Taiwan.
Chiang TE; Lin YC; Li YH; Wu CT; Kuo CS; Chen YW
Clin Oral Investig; 2019 May; 23(5):2395-2402. PubMed ID: 30302607
[TBL] [Abstract][Full Text] [Related]
24. Molecular profiling of oral squamous cell carcinoma associated with oral submucous fibrosis.
Choudhari S; Masne S; Bhandare P; Dhumal S
J Cancer Res Ther; 2022; 18(1):55-65. PubMed ID: 35381762
[TBL] [Abstract][Full Text] [Related]
25. Patterns of differentially expressed genes in oral mucosal lesions visualised under autofluorescence (VELscope(™) ).
Kordbacheh F; Bhatia N; Farah CS
Oral Dis; 2016 May; 22(4):285-96. PubMed ID: 26749103
[TBL] [Abstract][Full Text] [Related]
26. Portable LED-induced autofluorescence spectroscopy for oral cancer diagnosis.
Yan YJ; Huang TW; Cheng NL; Hsieh YF; Tsai MH; Chiou JC; Duann JR; Lin YJ; Yang CS; Ou-Yang M
J Biomed Opt; 2017 Apr; 22(4):45007. PubMed ID: 28421226
[TBL] [Abstract][Full Text] [Related]
27. [Application of near infrared fluorescence imaging in detection of residual cancer in oral squamous cell carcinoma].
Zhang Q; Xia CW; Hu SQ; Wang Y; Pu YM; Wang YX
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):450-454. PubMed ID: 35615804
[No Abstract] [Full Text] [Related]
28. Improved diagnosis of oral premalignant lesions in submucous fibrosis patients with 5-aminolevulinic acid induced PpIX fluorescence.
Wang CY; Tsai T; Chiang CP; Chen HM; Chen CT
J Biomed Opt; 2009; 14(4):044026. PubMed ID: 19725737
[TBL] [Abstract][Full Text] [Related]
29. Point-of-care devices based on fluorescence imaging and spectroscopy for tumor margin detection during breast cancer surgery: Towards breast conservation treatment.
Thapa P; Singh V; Gupta K; Shrivastava A; Kumar V; Kataria K; Mishra PR; Mehta DS
Lasers Surg Med; 2023 Apr; 55(4):423-436. PubMed ID: 36884000
[TBL] [Abstract][Full Text] [Related]
30.
Bagri-Manjrekar K; Chaudhary M; Sridharan G; Tekade SR; Gadbail AR; Khot K
J Cancer Res Ther; 2018; 14(3):553-558. PubMed ID: 29893315
[TBL] [Abstract][Full Text] [Related]
31. Assessment of serum synuclein-γ and squamous cell carcinoma antigen as diagnostic biomarkers in patients with oral squamous cell carcinoma and oral potentially malignant disorders.
Chen L; Luo T; Yang J; Wang K; Liu S; Wei Y; Liu H; Xu J; Zheng J; Zeng Y
J Oral Pathol Med; 2021 Feb; 50(2):165-174. PubMed ID: 33064859
[TBL] [Abstract][Full Text] [Related]
32. Ki67, CD105, and α-SMA Expression Supports Biological Distinctness of Oral Squamous Cell Carcinoma Arising in the Background of Oral Submucous Fibrosis.
Gadbail AR; Korde S; Chaudhary MS; Sarode SC; Gondivkar SM; Dande R; Tekade SA; Yuwanati M; Hande A; Patil S
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2067-2074. PubMed ID: 32711434
[TBL] [Abstract][Full Text] [Related]
33. NOVEL USE OF FLUORESCEIN DYE IN DETECTION OF ORAL DYSPLASIA AND ORAL CANCER.
Qaiser D; Sood A; Mishra D; Kharbanda OP; Srivastava A; Gupta SD; Pandey RM; Yadav R; Bhatt K; Kumawat R
Photodiagnosis Photodyn Ther; 2020 Sep; 31():101824. PubMed ID: 32450303
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of programmed death-1 and its ligand, programmed death ligand-1 in oral squamous cell carcinoma with and without oral submucous fibrosis.
Quan H; Liu S; Shan Z; Liu Z; Chen T; Hu Y; Yao Z; Fang L
Arch Oral Biol; 2020 Nov; 119():104916. PubMed ID: 32977151
[TBL] [Abstract][Full Text] [Related]
35. AI-based analysis of oral lesions using novel deep convolutional neural networks for early detection of oral cancer.
Warin K; Limprasert W; Suebnukarn S; Jinaporntham S; Jantana P; Vicharueang S
PLoS One; 2022; 17(8):e0273508. PubMed ID: 36001628
[TBL] [Abstract][Full Text] [Related]
36. Autofluorescence spectroscopy for the in vivo evaluation of oral submucous fibrosis.
Haris PS; Balan A; Jayasree RS; Gupta AK
Photomed Laser Surg; 2009 Oct; 27(5):757-61. PubMed ID: 19712020
[TBL] [Abstract][Full Text] [Related]
37. Malignant transformation in 5071 southern Taiwanese patients with potentially malignant oral mucosal disorders.
Wang YY; Tail YH; Wang WC; Chen CY; Kao YH; Chen YK; Chen CH
BMC Oral Health; 2014 Aug; 14():99. PubMed ID: 25096230
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Value of Cancer Stem Cell Markers in Potentially Malignant Disorders of Oral Mucosa: A Meta-analysis.
Saluja TS; Ali M; Mishra P; Kumar V; Singh SK
Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):144-153. PubMed ID: 30315141
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
Varun BR; Ranganathan K; Rao UK; Joshua E
J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
[TBL] [Abstract][Full Text] [Related]
40. Low LINC02147 expression promotes the malignant progression of oral submucous fibrosis.
Chen J; Li W; Liu B; Xie X
BMC Oral Health; 2022 Jul; 22(1):316. PubMed ID: 35906577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
